SPIR:NYSESpire Global, Inc. Analysis
Data as of 2026-09-06 - not real-time
$11.98
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Spire Global, Inc. is neutral at $11.98, with no clear ordering between short and long averages. The last 30 days have gained 9.0%. Momentum indicators put RSI at 37.4 (approaching oversold) with MACD reading bearish. The recent range runs from support at $11.32 up to resistance at $15.16.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 74.2% above where the shares trade now. Revenue is contracting at 5.9% on a -145.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 69.6%, a beta of 3.51 and a maximum drawdown of 58.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 74.2% above where the shares trade now. Revenue is contracting at 5.9% on a -145.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 69.6%, a beta of 3.51 and a maximum drawdown of 58.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.
Top Market Events
Spire Global Inc SPIR reports its strongest core revenue quarter since the maritime divestiture, with Q2 revenue up 16%...Spire SPIR might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a...Spire Global SPIR just checked off another important milestone in its growth strategy.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 13.44
- MACD momentum is negative
- 30-day price change of +9.0%
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 13.44
- Analyst targets imply +74.2% versus the current price
- 30-day volatility of 69.6%
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative profit margin of -145.2%
- Analyst targets imply +74.2% versus the current price
- Negative return on equity of -61.7%
Key Metrics & Analysis
Financial Health
Revenue Growth-5.90%
Profit Margin-145.22%
P/E Ratio-30.7
ROE-61.72%
ROA-22.02%
Debt/Equity6.72
P/B Ratio4.4
Op. Cash Flow$-65909000
Free Cash Flow$-52565752
Industry P/E28.5
Technical Analysis
TrendNeutral
RSI37.4
Support$11.32
Resistance$15.16
MA 20$13.50
MA 50$13.72
MA 200$13.44
MACDBearish
VolumeStable
Fear & Greed Index95.48
Valuation
Target Price$20.88
Upside/Downside74.25%
GradeFair
TypeBlend
Risk Assessment
Beta3.51
Volatility69.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.